Due to the nature of our potential treatment for AD, Curaxis conducts separate trials for men and women.

Curaxis Pharmaceutical Corp. is currently preparing for a Phase 2 Clinical Trial using Luteinizing Hormone (LH) in women. This trial is expected to launch in 2010 and will be designed by Curaxis and its clinical consultants.

If you would like to be considered for this trial, or would like more information about the trial as it becomes available, please register using the Trial Application Form or contact via email at trialinfo@curaxispharma.com

We endeavor to reply in a timely manner to each and every inquiry. However, due to the volume of requests, we may only reply as information becomes available. Thank you for your patience.